Abstract
Compensatory hyperhidrosis (CH) is the most common and most feared adverse effect of thoracic sympathectomy and the complaint is mainly of increased sweat of the chest, abdomen, legs, and buttocks. Studies show that practically all patients will have some degree of this complication, but more than 11.6% of patients develop a severe CH with a social impact as bad or worse than the preoperative status. The first-line treatment is the oral use of anticholinergic medications, mainly oxybutynin.
Keywords
- Compensatory hyperhidrosis
- Oxybutynin
- Sympathectomy
- Sweat
This is a preview of subscription content, access via your institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSuggested Reading
de Campos JR, Wolosker N, Takeda FR, et al. The body mass index and level of resection: predictive factors for compensatory sweating after sympathectomy. Clin Auton Res. 2005;15(2):116–20.
Gong TK, Kim DW. Effectiveness of oral glycopyrrolate use in compensatory hyperhidrosis patients. Korean J Pain. 2013;26(1):89–93.
Lowe N, Campanati A, Bodokh I, et al. The place of botulinum toxin type A in the treatment of focal hyperhidrosis. Br J Dermatol. 2004;151(6):1115–22.
Milanez de Campos JR, Kauffman P, Gomes O Jr, Wolosker N. Video-assisted thoracic sympathectomy for hyperhidrosis. Thorac Surg Clin. 2016;26(3):347–58.
Prouty ME, Fischer R, Liu D. Glycopyrrolate-induced craniofacial compensatory hyperhidrosis successfully treated with oxybutynin: report of a novel adverse effect and subsequent successful treatment. Dermatol Online J. 2016;22(10):15.
Teivelis MP, Varella AY, Wolosker N. Expanded level of sympathectomy and incidence or severity of compensatory hyperhidrosis. J Thorac Cardiovasc Surg. 2014;148(5):2443–4.
Teivelis MP, Wolosker N, Krutman M, et al. Compensatory hyperhidrosis: results of pharmacologic treatment with oxybutynin. Ann Thorac Surg. 2014;98(5):1797–802.
Wolosker N, Yazbek G, Ishy A, et al. Is sympathectomy at T4 level better than at T3 level for treating palmar hyperhidrosis? J Laparoendosc Adv Surg Tech A. 2008;18(1):102–6.
Wolosker N, Teivelis MP, Krutman M, et al. Long-term results of the use of oxybutynin for the treatment of axillary hyperhidrosis. Ann Vasc Surg. 2014;28(5):1106–12.
Yazbek G, Wolosker N, Kauffman P, et al. Twenty months of evolution following sympathectomy on patients with palmar hyperhidrosis: sympathectomy at the T3 level is better than at the T2 level. Clinics (Sao Paulo). 2009;64(8):743–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Leiderman, D.B.D., Yazbec, G., Wolosker, N. (2018). Management of Compensatory Hyperhidrosis. In: Loureiro, M., Campos, J., Wolosker, N., Kauffman, P. (eds) Hyperhidrosis. Springer, Cham. https://doi.org/10.1007/978-3-319-89527-7_26
Download citation
DOI: https://doi.org/10.1007/978-3-319-89527-7_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-89526-0
Online ISBN: 978-3-319-89527-7
eBook Packages: MedicineMedicine (R0)